RAP2A and cancer: Figures 5A–O show the expression of the 15 gene signatures [PRDX6 (Figure 5A), GCLM (Figure 5B), HTATIP2 (Figure 5C), SEMA3F (Figure 5D), UCK2 (Figure 5E), NOL10 (Figure 5F), KIF18A (Figure 5G), RAP2A (Figure 5H), BOD1 (Figure 5I), GDI2 (Figure 5J), ZIC2 (Figure 5K), GTF3C6 (Figure 5L), SLC1A5 (Figure 5M), ERI3 (Figure 5N) and SAC3D1 (Figure 5O)] in LIHC cancer tissues relative to that in paraneoplastic tissues and different cancer stages.